The Balancing Act Ups Awareness on Hereditary ATTR Amyloidosis on Episode Airing on May 16th
May 12, 2016
Raising Awareness on Hereditary ATTR Amyloidosis – with Alnylam Pharmaceuticals
On this Behind the Mystery: Rare & Genetic segment, third cousins, 44-year-old Dawn and 42-year-old Christina discuss how the disease has impacted their lives and the lives of their families.
Hereditary ATTR amyloidosis (hATTR amyloidosis) is an inherited, progressive, life-threatening disease. It is due to a mutation in the transthyretin (TTR) gene, which causes misfolded TTR proteins to accumulate as amyloid fibrils in multiple organs, but primarily in the peripheral nerves and heart. hATTR amyloidosis can lead to significant morbidity, disability, and mortality. Its symptoms are diverse and similar to other conditions, which means that many patients are often misdiagnosed or go undiagnosed. However, because it is a genetic condition, family history plays a crucial role in accurate and timely diagnosis.
To learn about symptoms, treatment options and more, go to www.TTRscreen.com.
Sign up for updates straight to your inbox.